Statera BioPharma Inc (STAB)

[goforthebet]

that is wrong. IMUN owns a part of Cytocom

For Immune Therapeutics, Inc. (Ticker: IMUN) and it’s shareholders who hold a considerable stake in Cytocom this means that the value for all of the years of support and collaboration with Cytocom can be realized. The Cytocom platform technologies and product pipeline, in combination with Cleveland BioLabs, have the potential to drive significant future growth in Immune’s shareholder value.

https://www.globenewswire.com/news-release/2020/10/20/2111251/0/en/Immune-Therapeutics-Inc-Announces-Signing-of-Definitive-Merger-Agreement-Between-Cytocom-and-Cleveland-BioLabs.html

filing:https://www.sec.gov/Archives/edgar/data/1559356/000149315219007850/ex10-60.htm

2. Confirmation of Ownership of Cytocom Inc, by Company. The Parties confirm and agree that in accordance with the Stock Purchase Agreement signed by the Parties on June 4, 2018, as of the Effective Date IMUN owns common stock of CYTO representing 15.57% of the outstanding common shares of CYTO as of the Effective Date, and that, in the event that CYTO issues additional shares after the Effective Date and up to and including the completion of a Series A round in an amount greater than $3 million, or IPO, or Sale of CYTO, CYTO will cause additional shares to be issued to IMUN in such number that IMUN’s percentage of outstanding common stock will not fall below 15.57%.